ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009